Related Experiment Video
Updated: May 6, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Atopic dermatitis and chronic sinusitis: a two-sample Mendelian randomized study
Jian Luo1, Yuanzhi Zhu1, Yuting Zhang1
1The First People's Hospital of Yibin, Department of Otorhinolaryngology, Yibin, Sichuan, China.
Objectives:
Despite observational studies have indicated a potential association between Atopic Dermatitis (AD) and Chronic Sinusitis (CRS), it is uncertain whether there is a causal relationship between AD and CRS. To address this ambiguity, a two-sample bidirectional Mendelian randomization methodology was utilized to examine the potential causal association between AD with CRS.
Methods:
The summary data for the Genome-Wide Association Study (GWAS) on AD and CRS were sourced from the FinnGen consortium. To investigate the causal link between AD and CRS, we applied several approaches, including Inverse-Variance Weighting (IVW), MR-Egger regression, weighted median, simple mode, and weighted mode methods. Furthermore, the heterogeneity, horizontal pleiotropy, and sensitivity were investigated using several methods.
Results:
Based on the random-effect IVW approach, results showed a 15.8% increased risk of CRS in those with AD compared with non-AD populations (p = 7.771e-07, OR = 1.158, 95% CI 1.092-1.227). Inversely, there was no direct evidence that CR increased the risk of AD (p = 0.979, OR = 1.001, 95% CI 0.908-1.104). The MR-Egger intercept test results indicated an absence of horizontal pleiotropy in this study (AD: p = 0.381; CRS: p = 0.144). Additionally, the leave-one-out test demonstrated the results of both forward and backward analyses were reliable and robust.
Conclusion:
Our study confirmed the causal effect of AD on CRS, with AD increasing the risk of developing CRS. Conversely, CRS did not affect the risk of developing AD. Our study suggested that in the prevention and treatment of CRS, physicians cannot ignore the impact of AD on CRS.
Level Of Evidence:
Level 2.

